These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5930685)

  • 1. Comparative activity of 1-beta-d-arabinofuranosyl-5-fluorocytosine and related compounds against transplanted mouse leukemias in vivo and in vitro.
    Burchenal JH; Adams HH; Newell NS; Fox JJ
    Cancer Res; 1966 Mar; 26(3):370-3. PubMed ID: 5930685
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
    Burchenal JH; O'Toole T; Kalaher K; Chisholm J
    Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the antitumor and antiviral activity of 1-beta-D-arabinofuranosyl-5-fluorocytosine (FCA) and 1-beta-D-arabinofuranosylcytosine (CA).
    Prince HN; Grunberg E; Buck M; Cleeland R
    Proc Soc Exp Biol Med; 1969 Apr; 130(4):1080-6. PubMed ID: 4305347
    [No Abstract]   [Full Text] [Related]  

  • 4. A proposed mechanism of action of 1-beta-D-arabinofuranosyl-cytosine as an inhibitor of the growth of leukemic cells.
    CHU MY; FISCHER GA
    Biochem Pharmacol; 1962 Jun; 11():423-30. PubMed ID: 13879359
    [No Abstract]   [Full Text] [Related]  

  • 5. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
    J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of 1-beta-D-arabinofuranosyl-5-fluorocytosine on the nucleic acid metabolism and viability of HeLa cells.
    Kim JH; Eidinoff ML; Fox JJ
    Cancer Res; 1966 Aug; 26(8):1661-4. PubMed ID: 5923164
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

  • 8. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 10. 5'-Phosphoramidates and 5'-diphosphates of 2'-O-allyl-beta-D-arabinofuranosyluracil, -cytosine, and -adenine: inhibition of ribonucleotide reductase.
    Manfredini S; Baraldi PG; Durini E; Vertuani S; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
    J Med Chem; 1999 Aug; 42(17):3243-50. PubMed ID: 10464011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 1-beta-D-arabinofuranosylcytosine hydrochloride on regenerating bone marrow.
    Papac RJ; Calabresi P; Hollingsworth JW; Welch AD
    Cancer Res; 1965 Oct; 25(9):1459-62. PubMed ID: 5323960
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OETTGEN HF, REPPERT JA, COLEY V: Studies on the synergism of fluorinated pyrimidines and certain pyrimidine and purine derivatives against transplanted mouse leukemia.
    BURCHENAL JH
    Cancer Chemother Rep; 1960 Feb; 6():1-5. PubMed ID: 13806003
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
    Meade EA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral properties of nucleosides structurally related to 1-beta-d-arabinofuranosylcytosine.
    Renis HE; Underwood GE; Hunter JH
    Antimicrob Agents Chemother (Bethesda); 1967; 7():675-9. PubMed ID: 5596204
    [No Abstract]   [Full Text] [Related]  

  • 16. Nucleosides. XXIX. 1-beta-D-arabinofuranosyl-5-fluorocytosine and related arabino nucleosides.
    Fox JJ; Miller N; Wempen I
    J Med Chem; 1966 Jan; 9(1):101-5. PubMed ID: 5958936
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
    Ho DH; Frei E
    Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
    [No Abstract]   [Full Text] [Related]  

  • 18. Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
    Matsuda A; Nakajima Y; Azuma A; Tanaka M; Sasaki T
    J Med Chem; 1991 Sep; 34(9):2917-9. PubMed ID: 1895307
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
    Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T; Oh-Hara T; Sudo Y; Naito M
    Anticancer Res; 1993; 13(2):357-61. PubMed ID: 8517647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.